Should I buy or sell FinecoBank Banca Fineco stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FinecoBank Banca Fineco in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FCBBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FCBBF, but not buy additional shares or sell existing shares. View FCBBF analyst ratings or view top-rated stocks .

How have FCBBF shares performed in 2024?

FinecoBank Banca Fineco's stock was trading at $12.50 at the beginning of 2024. Since then, FCBBF stock has increased by 11.1% and is now trading at $13.89. View the best growth stocks for 2024 here .

Are investors shorting FinecoBank Banca Fineco?

FinecoBank Banca Fineco saw a decrease in short interest in March. As of March 31st, there was short interest totaling 10,408,100 shares, a decrease of 7.8% from the March 15th total of 11,290,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 104,081.0 days. View FinecoBank Banca Fineco's Short Interest .

How do I buy shares of FinecoBank Banca Fineco?

Shares of FCBBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:FCBBF

FinecoBank Banca Fineco (FCBBF) Stock Price, News & Analysis

→ Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad)

Free FCBBF Stock Alerts

$13.89

0.00 (0.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: $13.89
▼
$13.89
50-Day Range: $13.89
▼
$13.89
52-Week Range: $10.66
▼
$13.96

Volume: N/A
Average Volume: 350 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get FinecoBank Banca Fineco alerts:

Ad Behind the Markets

Jim Cramer’s “The Biggest Drug Ever”

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

About FinecoBank Banca Fineco Stock (OTCMKTS:FCBBF)

FinecoBank Banca Fineco S.p.A. provides banking and investment products and services. The company offers banking services, including current account and deposit services, payment services, mortgages, overdrafts, and personal loans, as well as debit, credit, and prepaid cards; and brokerage services comprising order execution services on behalf of customers with direct access to global equity markets, as well as trading of CFDs, futures, options, bonds, ETFs, and certificates. It also provides asset management services, such as placement and distribution services of various products, including units issued by investment funds and SICAV shares, and insurance and pension products, as well as investment advisory services. The company serves primarily through a network of personal financial advisors, and online and mobile channels. It operates financial shops. The company was founded in 1999 and is headquartered in Reggio Emilia, Italy.

FCBBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FCBBF Stock News Headlines

November 17, 2021 | nasdaq.com

Italy's FinecoBank allays antitrust concerns over move on 100,000 euros deposits

November 10, 2021 | finance.yahoo.com

FinecoBank continues rapid UK growth

April 26, 2024 | Behind the Markets (Ad)

Jim Cramer’s “The Biggest Drug Ever”

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

August 3, 2021 | reuters.com

UPDATE 1-FinecoBank expects $1 bln July inflows, plans 2022 German debut

August 2, 2021 | markets.businessinsider.com

FinecoBank earnings: here's what Wall Street expects

See More Headlines

Receive FCBBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FinecoBank Banca Fineco and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Financial Services
Industry: Banks - Regional
Sub-Industry: N/A
Current Symbol: OTCMKTS:FCBBF
CUSIP: N/A
CIK: N/A
Web: www.finecobank.com
Phone: 39-08-00-92-92-92
Fax: N/A
Employees: 1,384
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Alessandro Foti (Age 64)
CEO, GM & Executive Director
Comp: $1.48M
Ms. Lorena Pelliciari (Age 64)
Chief Financial Officer
Mr. Fabio Milanesi
Deputy GM and Head of It, Operations & Customer Care
Gianluca Fontanella
Head of Investor Relations
Mr. Silvio Puchar
Chief Compliance Officer
Mr. Andrea Pepe
Head of Legal & Corporate Affairs Department
Mr. Paolo Di Grazia
Deputy GM & Head of Global Business
Mr. Mauro Albanese
Deputy GM and Head of Network PFA & Private Banking
Patrizia Verdesca
Head of Internal Audit
Mr. Giovanni Boneschi
Chief Risk Officer

Key Competitors

View All Competitors

FCBBF Stock Analysis - Frequently Asked Questions

Should I buy or sell FinecoBank Banca Fineco stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FinecoBank Banca Fineco in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FCBBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FCBBF, but not buy additional shares or sell existing shares.
View FCBBF analyst ratings or view top-rated stocks.
How have FCBBF shares performed in 2024?: FinecoBank Banca Fineco's stock was trading at $12.50 at the beginning of 2024. Since then, FCBBF stock has increased by 11.1% and is now trading at $13.89.
View the best growth stocks for 2024 here.
Are investors shorting FinecoBank Banca Fineco?: FinecoBank Banca Fineco saw a decrease in short interest in March. As of March 31st, there was short interest totaling 10,408,100 shares, a decrease of 7.8% from the March 15th total of 11,290,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 104,081.0 days.
View FinecoBank Banca Fineco's Short Interest.
How do I buy shares of FinecoBank Banca Fineco?: Shares of FCBBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FCBBF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial